These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36081392)

  • 1. Increased risk of dialysis circuit clotting in hemodialysis patients with COVID-19 is associated with elevated FVIII, fibrinogen and D-dimers.
    Sudusinghe D; Riddell A; Gandhi T; Chowdary P; Davenport A
    Hemodial Int; 2023 Jan; 27(1):38-44. PubMed ID: 36081392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of SARS-Co-V2 infection on prothrombotic and anticoagulant factors in dialysis patients.
    Riddell A; Chowdary P; Davenport A
    Artif Organs; 2022 Jul; 46(7):1328-1333. PubMed ID: 35167146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialysis circuit clotting in critically ill patients with COVID-19 infection.
    Khoo BZE; Lim RS; See YP; Yeo SC
    BMC Nephrol; 2021 Apr; 22(1):141. PubMed ID: 33879086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio].
    Barata JD; Oliveira C; Bruges M; Gusmão L; Santana A; Ponce P; Simões J; Freire I; Crespo F; da Silva AN
    Acta Med Port; 1992 Feb; 5(2):65-70. PubMed ID: 1317657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cov-hep study: heparin in standard anticoagulation based on citrate for continuous veno-venous hemodialysis in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
    Lins PRG; de Albuquerque CCC; Assis CF; Rodrigues BCD; E Siqueira Campos BP; de Oliveira Valle E; Cabrera CPS; de Oliveira Gois J; Segura GC; Strufaldi FL; Mainardes LC; Ribeiro RG; Via Reque Cortes DDP; Lutf LG; de Oliveira MFA; Sales GTM; Smolentzov I; Reichert BV; Andrade L; Seabra VF; Rodrigues CE
    Trials; 2020 Nov; 21(1):920. PubMed ID: 33176886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete blood count, coagulation biomarkers, and lung function 6 months after critical COVID-19.
    Kattainen S; Pitkänen H; Reijula J; Hästbacka J
    Acta Anaesthesiol Scand; 2024 Aug; 68(7):940-948. PubMed ID: 38723274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of plasminogen activator inhibitor type 1, factor VIII, prothrombin activation fragment 1+2, anticardiolipin, and antiprothrombin antibodies are risk factors for thrombosis in hemodialysis patients.
    Molino D; De Santo NG; Marotta R; Anastasio P; Mosavat M; De Lucia D
    Semin Nephrol; 2004 Sep; 24(5):495-501. PubMed ID: 15490419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study.
    Bocci MG; Maviglia R; Consalvo LM; Grieco DL; Montini L; Mercurio G; Nardi G; Pisapia L; Cutuli SL; Biasucci DG; Gori C; Rosenkranz R; De Candia E; Carelli S; Natalini D; Antonelli M; Franceschi F
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12466-12479. PubMed ID: 33336766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of PEG-Hirudin in chronic hemodialysis monitored by the Ecarin Clotting Time: influence on clotting of the extracorporeal system and hemostatic parameters.
    Ulbricht K; Bucha E; Pöschel KA; Stein G; Wolf G; Nowak G
    Clin Nephrol; 2006 Mar; 65(3):180-90. PubMed ID: 16550749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin III and Factor VIII in patients with neoplasms.
    Losito R; Beaudry P; Valderrama JC; Cousineau L; Longpré B
    Am J Clin Pathol; 1977 Aug; 68(2):258-62. PubMed ID: 879100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clotting of Hemodialysis Access in Patients with COVID-19 in an Inner-City Hospital.
    Ouyang J; Bajracharya S; John S; Wagner J; Xu J; Luo Y; Thaxton M; Salifu M; Yap E; Mallappallil M
    Nephron; 2022; 146(2):179-184. PubMed ID: 34929702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet activation and clotting cascade activation by dialyzers designed for high volume online hemodiafiltration.
    Tangvoraphonkchai K; Riddell A; Davenport A
    Hemodial Int; 2018 Apr; 22(2):192-200. PubMed ID: 28762633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaemia and enhancement of coagulation are associated with severe COVID-19 infection.
    Helin TA; Lemponen M; Lahtiharju T; Koskinen M; Lassila R; Joutsi-Korhonen L
    Scand J Clin Lab Invest; 2021 Dec; 81(8):653-660. PubMed ID: 34793272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infants.
    Urlesberger B; Zobel G; Zenz W; Kuttnig-Haim M; Maurer U; Reiterer F; Riccabona M; Dacar D; Gallisti S; Leschnik B; Muntean W
    J Pediatr; 1996 Aug; 129(2):264-8. PubMed ID: 8765625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodialysis without heparin: a randomized, controlled, crossover study of two dialysis membranes (AN69ST and polysulfone F60).
    Brunet P; Frances J; Vacher-Coponat H; Jaubert D; Lebrun G; Gondouin B; Duval A; Berland Y
    Int J Artif Organs; 2011 Dec; 34(12):1165-71. PubMed ID: 22198602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of coagulation during hemodialysis: effect of blood lines alone and whole extracorporeal circuit.
    Lucchi L; Ligabue G; Marietta M; Delnevo A; Malagoli M; Perrone S; Stipo L; Grandi F; Albertazzi A
    Artif Organs; 2006 Feb; 30(2):106-10. PubMed ID: 16433843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for early hemorrhagic and thrombotic complications after kidney transplantation.
    Pawlicki J; Cierpka L; Król R; Ziaja J
    Transplant Proc; 2011 Oct; 43(8):3013-7. PubMed ID: 21996213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of circuit and AV fistula clotting and detection of anti-PF4/heparin complex antibodies in hemodialysis patients suspected of having heparin-induced thrombocytopenia.
    Matsuo T; Wanaka K; Walenga JM
    Clin Appl Thromb Hemost; 2013; 19(1):73-8. PubMed ID: 22345486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications.
    Voicu S; Delrue M; Chousterman BG; Stépanian A; Bonnin P; Malissin I; Deye N; Neuwirth M; Ketfi C; Mebazaa A; Siguret V; Mégarbane B
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9161-9168. PubMed ID: 32965009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin dosage, level, and resistance in SARS-CoV2 infected patients in intensive care unit.
    Novelli C; Borotto E; Beverina I; Punzi V; Radrizzani D; Brando B
    Int J Lab Hematol; 2021 Dec; 43(6):1284-1290. PubMed ID: 33855802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.